Patrolling monocytes control tumor metastasis to the lung

Science

Volumn 350, Issue 6263, 2015, Pages 985-990

  Hanna, Richard N ^a   Cekic, Caglar ^b   Sag, Duygu ^c   Tacke, Robert ^a   Thomas, Graham D ^a   Nowyhed, Heba ^a   Herrley, Erica ^a   Rasquinha, Nicole ^a   McArdle, Sara ^a   Wu, Runpei ^a   Peluso, Esther ^a   Metzger, Daniel ^d   Ichinose, Hiroshi ^e   Shaked, Iftach ^a   Chodaczek, Grzegorz ^a   Biswas, Subhra K ^f   Hedrick, Catherine C ^a  

^a LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

^b BILKENT UNIVERSITY   (Turkey)

^c DOKUZ EYLUL UNIVERSITY   (Turkey)

^d UNIVERSITÉ DE STRASBOURG   (France)

^e TOKYO INSTITUTE OF TECHNOLOGY   (Japan)

^f AGENCY FOR SCIENCE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ANATOMY; BLOOD; CANCER; CELLS AND CELL COMPONENTS; DISEASE TREATMENT; IMMUNE SYSTEM; RESPIRATORY DISEASE; RODENT; TUMOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CONTROL; CELL INTERACTION; CELL SPECIFICITY; CELL TRANSFER; CONTROLLED STUDY; FEMALE; IN VIVO STUDY; LUNG METASTASIS; MICROVASCULATURE; MONOCYTE; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; TUMOR CELL; TUMOR INVASION; ANIMAL; EXPERIMENTAL NEOPLASM; GENETICS; IMMUNOLOGY; IMMUNOSURVEILLANCE; IMMUNOTHERAPY; LUNG NEOPLASMS; METASTASIS; MUTANT MOUSE STRAIN; PROCEDURES; SECONDARY;

MUS;

NR4A1 PROTEIN, MOUSE; NUCLEAR RECEPTOR NUR77;

ANIMALS; IMMUNOLOGIC SURVEILLANCE; IMMUNOTHERAPY; KILLER CELLS, NATURAL; LUNG NEOPLASMS; MICE; MICE, MUTANT STRAINS; MONOCYTES; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASMS, EXPERIMENTAL; NUCLEAR RECEPTOR SUBFAMILY 4, GROUP A, MEMBER 1;

EID: 84947754755     PISSN: 00368075     EISSN: 10959203     Source Type: Journal    
DOI: 10.1126/science.aac9407     Document Type: Article

References (39)

1. S. K. Biswas, A. Mantovani, Nat. Immunol. 11, 889-896 (2010).
2. P. J. Murray, T. A. Wynn, Nat. Rev. Immunol. 11, 723-737 (2011).
3. T. A. Wynn, A. Chawla, J. W. Pollard, Nature 496, 445-455 (2013).
4. R. A. Franklin et al., Science 344, 921-925 (2014).
5. B. Z. Qian et al., Nature 475, 222-225 (2011).
6. K. Movahedi et al., Cancer Res. 70, 5728-5739 (2010).
7. L. M. Carlin et al., Cell 153, 362-375 (2013).
8. J. Cros et al., Immunity 33, 375-386 (2010).
9. C. Auffray et al., Science 317, 666-670 (2007).
10. R. N. Hanna et al., Nat. Immunol. 12, 778-785 (2011).
11. A. E. Moran et al., J. Exp. Med. 208, 1279-1289 (2011).
12. L. Landsman, S. Jung, J. Immunol. 179, 3488-3494 (2007).
13. L. Landsman, C. Varol, S. Jung, J. Immunol. 178, 2000-2007 (2007).
14. C. Jakubzick et al., J. Immunol. 180, 3019-3027 (2008).
15. C. T. Guy, R. D. Cardiff, W. J. Muller, Mol. Cell. Biol. 12, 954-961 (1992).
16. S. Saeed et al., Science 345, 1251086 (2014).
17. V. Jojic et al., Nat. Immunol. 14, 633-643 (2013).
18. D. E. Sanford et al., Clin. Cancer Res. 19, 3404-3415 (2013).
19. P. Vader, X. O. Breakefield, M. J. Wood, Trends Mol. Med. 20, 385-393 (2014).
20. F. Pucci, M. J. Pittet, Clin. Cancer Res. 19, 2598-2604 (2013).
21. R. N. Hanna et al., Circ. Res. 110, 416-427 (2012).
22. G. Thomas, R. Tacke, C. C. Hedrick, R. N. Hanna, Arterioscler. Thromb. Vasc. Biol. 35, 1306-1316 (2015).
23. S. Jung et al., Mol. Cell. Biol. 20, 4106-4114 (2000).
24. F. Geissmann, S. Jung, D. R. Littman, Immunity 19, 71-82 (2003).
25. Y. R. Yu et al., Int. J. Cancer 121, 316-322 (2007).
26. L. Landsman et al., Blood 113, 963-972 (2009).
27. A. I. Su et al., Proc. Natl. Acad. Sci. U. S. A. 101, 6062-6067 (2004).
28. K. W. Kim et al., Blood 118, e156-e167 (2011).
29. J. Zhang, J. M. Patel, Int. J. Clin. Exp. Med. 3, 233-244 (2010).
30. E. Ferretti, V. Pistoia, A. Corcione, Mediators Inflamm. 2014, 480941 (2014).
31. M. Hyakudomi et al., Ann. Surg. Oncol. 15, 1775-1782 (2008).
32. J. Y. Kee et al., Mol. Clin. Oncol. 1, 35-40 (2013).
33. M. H. Park, J. S. Lee, J. H. Yoon, J. Surg. Oncol. 106, 386-392 (2012).
34. A. Schmall et al., Am. J. Respir. Crit. Care Med. 191, 437-447 (2015).
35. M. Tardaguila, S. Manes, "The complex role of chemokines in cancer: The case of the CX3CL1-CX3CR1 axis", in Oncology: Theory and Practice (iConcept Press, 2014).
36. E. Romano et al., Proc. Natl. Acad. Sci. U. S. A. 112, 6140-6145 (2015).
37. A. Szaflarska et al., Exp. Hematol. 32, 748-755 (2004).
38. A. A. Maghazachi, Curr. Top. Microbiol. Immunol. 341, 37-58 (2010).
39. M. J. Robertson, J. Leukoc. Biol. 71, 173-183 (2002).